Synta Announces Initiation Of I-SPY 2 TRIAL Of Ganetespib In Breast Cancer

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.